← Insider buys
RNA

Atrium Therapeutics, Inc. · Healthcare

President and CEO Sarah Boyce sold $11.6M of Atrium Therapeutics, Inc.

Sold$11,588,306
$38.63Price
300,000Shares
−73%Stake

What RNA did after the filing

Prices for RNA after this filing aren't in yet.

Traded Wed, Jun 12. Filed Fri, Jun 14, 2:58 PM ET, during the session. Not investment advice.